日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cross-species insights: Optimizing chimeric antigen receptor T cell therapy in humans with insights from dogs

跨物种启示:借鉴犬类经验优化人类嵌合抗原受体T细胞疗法

Pan, Bin; Gale, Robert Peter; Yan, Zhiling

Association of EGFR and EGF gene polymorphisms with cervical cancer in a case-control study and cross-cancer meta-analysis

EGFR和EGF基因多态性与宫颈癌的关联:病例对照研究和跨癌种荟萃分析

Shi, Yuhan; Yao, Yueting; He, Fengquan; Chen, Xueya; Xu, Jinmei; Yan, Zhiling; Shi, Li; Yao, Yufeng

Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study

单中心回顾性研究表明,异基因造血干细胞移植前短期高剂量阿糖胞苷巩固治疗可改善急性髓系白血病患者的2年无复发生存期,但不能改善总生存期。

Ma, Yu; Cheng, Yanyan; Sun, Yuting; Zhu, Xiaotong; Zhang, Huifang; Dhurel, Raj Singh; Zhang, Huanxin; Sun, Qian; Liu, Qiong; Chen, Wei; Cheng, Hai; Li, Zhenyu; Pan, Bin; Yan, Zhiling

The Association of EGFL7 Polymorphism and Expression with Cervical Cancer Susceptibility and Pathogenesis.

EGFL7多态性和表达与宫颈癌易感性和发病机制的关系。

Liu Weipeng, Niu Zhixin, Yan Zhiling, Shi Lei, Zhang Shao, Hong Chao, Dai Shuying, Shi Li, Yao Yufeng

Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma.

多发性骨髓瘤中抗 GPRC5D CAR T 细胞疗法后 GPRC5D 丢失的遗传和表观遗传机制。

Ma Sha, Xia Jieyun, Zhang Miao, Li Wenyu, Xiao Meng, Sha Yuqian, Wang Wenya, Zhou Jianteng, Wang Ying, Qi Kunming, Fu Chunling, Sun Zengtian, Zhou Dian, Sun Qian, Qiu Tingting, Yan Zhiling, Zhu Feng, Chen Wei, Cheng Hai, Sang Wei, Cao Jiang, Li Depeng, Li Zhenyu, Fulciniti Mariateresa, Yao Yao, Xu Kailin, Niu Mingshan

The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy

抗生素使用对接受 CAR-T 疗法治疗的复发/难治性多发性骨髓瘤患者预后的影响

Yin, Lingling; Lv, Bin; Ge, Jiao; Qi, Yuekun; Xia, Jieyun; Ma, Sha; Wang, Ying; Liu, Yang; Zhou, Dian; Cao, Jiang; Yan, Zhiling; Qi, Kunming; Sang, Wei; Li, Depeng; Cheng, Hai; Chen, Wei; Xu, Kailin; Gu, Weiying; Li, Zhenyu; Zhu, Feng

Lymphocyte/monocyte to lactate dehydrogenase ratio prior to lymphodepletion impact the outcomes of patients with diffused large B cell lymphoma undergoing CAR-T cell therapy

淋巴细胞清除前淋巴细胞/单核细胞与乳酸脱氢酶的比值会影响接受CAR-T细胞治疗的弥漫性大B细胞淋巴瘤患者的预后。

Li, Na; An, Na; Ma, Sha; Cao, Jiang; Zhu, Feng; Qi, Kunming; Yan, Zhiling; Cheng, Hai; Sang, Wei; Chen, Wei; Li, Depeng; Li, Zhenyu; Xu, Kailin; Wang, Ying

A generalist vision-language foundation model for diverse biomedical tasks

适用于多种生物医学任务的通用视觉语言基础模型

Zhang, Kai; Zhou, Rong; Adhikarla, Eashan; Yan, Zhiling; Liu, Yixin; Yu, Jun; Liu, Zhengliang; Chen, Xun; Davison, Brian D; Ren, Hui; Huang, Jing; Chen, Chen; Zhou, Yuyin; Fu, Sunyang; Liu, Wei; Liu, Tianming; Li, Xiang; Chen, Yong; He, Lifang; Zou, James; Li, Quanzheng; Liu, Hongfang; Sun, Lichao

Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation

异基因造血干细胞移植后复发患者接受供体CD19 CAR-T细胞治疗可获得长期生存

Zhang, Cheng; Wang, Xiaoqi; Yi, Hai; Wang, Yi; Yan, Zhiling; Zhou, Jian; Yang, Ting; Liang, Aibin; Wang, Zhen; Ma, Yingying; Wen, Qin; Gao, Lei; Gao, Li; Kong, Peiyan; Tan, Xu; Jiang, Erlie; Zhang, Xi

MA-SAM: Modality-agnostic SAM adaptation for 3D medical image segmentation

MA-SAM:一种与模态无关的SAM自适应方法,用于3D医学图像分割

Chen, Cheng; Miao, Juzheng; Wu, Dufan; Zhong, Aoxiao; Yan, Zhiling; Kim, Sekeun; Hu, Jiang; Liu, Zhengliang; Sun, Lichao; Li, Xiang; Liu, Tianming; Heng, Pheng-Ann; Li, Quanzheng